The Development of Gout Treat-To-Target booklet

Introduction: The treat-to-target serum uric acid approach is recommended in local and international guidelines on gout management. Instruction for initiation and dose escalation for urate lowering therapy may cause confusion to the patient. Our aim was to develop and validate Gout Treat-To-Target b...

Full description

Bibliographic Details
Published in:Medical Journal of Malaysia
Main Author: Mustafa N.; Isa M.R.; Baharuddin H.
Format: Article
Language:English
Published: Malaysian Medical Association 2024
Online Access:https://www.scopus.com/inward/record.uri?eid=2-s2.0-85183703331&partnerID=40&md5=1dfe69b306adaaeea5190c748726228e
id 2-s2.0-85183703331
spelling 2-s2.0-85183703331
Mustafa N.; Isa M.R.; Baharuddin H.
The Development of Gout Treat-To-Target booklet
2024
Medical Journal of Malaysia
79
1

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85183703331&partnerID=40&md5=1dfe69b306adaaeea5190c748726228e
Introduction: The treat-to-target serum uric acid approach is recommended in local and international guidelines on gout management. Instruction for initiation and dose escalation for urate lowering therapy may cause confusion to the patient. Our aim was to develop and validate Gout Treat-To-Target booklet to aid in patient education. Materials and methods: A content development team which consisted of three consultant rheumatologists developed the booklet. Content validation was performed by a panel of evaluators consisted of eleven physicians (four consultant rheumatologists, two clinical specialists, and five medical officers), who were involved in gout management. Face validation was performed by ten patients with gout. Results: Item-Content Validity Index ranged from 0.9 to 1 with regards to relevancy, clarity, ambiguity and simplicity. Side effects of uricosuric agents were added to the draft based on an evaluator’s comment. Item-Face Validity Index was 1, which indicated that all patients were in 100% agreement with all items. Conclusion: We developed and validated our Gout Treat-to-Target booklet. There was high agreement in I-FVI and I-CVI among physicians and patients. © 2024, Malaysian Medical Association. All rights reserved.
Malaysian Medical Association
3005283
English
Article

author Mustafa N.; Isa M.R.; Baharuddin H.
spellingShingle Mustafa N.; Isa M.R.; Baharuddin H.
The Development of Gout Treat-To-Target booklet
author_facet Mustafa N.; Isa M.R.; Baharuddin H.
author_sort Mustafa N.; Isa M.R.; Baharuddin H.
title The Development of Gout Treat-To-Target booklet
title_short The Development of Gout Treat-To-Target booklet
title_full The Development of Gout Treat-To-Target booklet
title_fullStr The Development of Gout Treat-To-Target booklet
title_full_unstemmed The Development of Gout Treat-To-Target booklet
title_sort The Development of Gout Treat-To-Target booklet
publishDate 2024
container_title Medical Journal of Malaysia
container_volume 79
container_issue 1
doi_str_mv
url https://www.scopus.com/inward/record.uri?eid=2-s2.0-85183703331&partnerID=40&md5=1dfe69b306adaaeea5190c748726228e
description Introduction: The treat-to-target serum uric acid approach is recommended in local and international guidelines on gout management. Instruction for initiation and dose escalation for urate lowering therapy may cause confusion to the patient. Our aim was to develop and validate Gout Treat-To-Target booklet to aid in patient education. Materials and methods: A content development team which consisted of three consultant rheumatologists developed the booklet. Content validation was performed by a panel of evaluators consisted of eleven physicians (four consultant rheumatologists, two clinical specialists, and five medical officers), who were involved in gout management. Face validation was performed by ten patients with gout. Results: Item-Content Validity Index ranged from 0.9 to 1 with regards to relevancy, clarity, ambiguity and simplicity. Side effects of uricosuric agents were added to the draft based on an evaluator’s comment. Item-Face Validity Index was 1, which indicated that all patients were in 100% agreement with all items. Conclusion: We developed and validated our Gout Treat-to-Target booklet. There was high agreement in I-FVI and I-CVI among physicians and patients. © 2024, Malaysian Medical Association. All rights reserved.
publisher Malaysian Medical Association
issn 3005283
language English
format Article
accesstype
record_format scopus
collection Scopus
_version_ 1809677575085096960